BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects

NCT00388492 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

INDIV

Sponsor class

Conditions

HIV Infections

Sponsor

Bellos, Nicholaos C., M.D.